Key facts
- Ascellus’s last known valuation is $20.0M (Nov 2020).
- It has raised $29.6M; the latest was Later Stage VC ($16.0M) in Mar 2026.
- Notable investors include Hartford Investment Management Company, .406 Ventures, Centripetal Capital Partners, HLM Investment Partners, Profound Ventures (California).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Ascellus
- ·The full record, as it builds
Funding rounds
No funding rounds for Ascellus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ascellus
Operator of trauma prevention and treatment clinics intended to treat employees suffering from chronic pain. The company's clinics deliver customized treatment options, reduce compensation claims costs, and empower injured workers to return to work sooner, enabling doctors and practitioners to restore their physical and emotional well-being.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2009
- Employees
- 54
- Website
- ascellus.com/
- Ownership
- Privately Held (backing)
Ascellus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ascellus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ascellus in its N-PORT filings yet. We sweep new filings monthly.